ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,030, issued on Oct. 14, was assigned to Laboratory Corporation of America Holdings (Burlington, N.C.).
"Methods and systems for determining ADAMTS13 enzyme activity" was invented by Russell Philip Grant (Chapel Hill, N.C.), Christopher Michael Shuford (Mebane, N.C.) and Meghan Norris Bradley (Mebane, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods and systems for the analysis activity of enzyme disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) in a sample. The methods and systems disclosed herein can be useful for diagnosis of thrombotic thrombocytopenic purpura in a patient."
The p...